Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease |
Ho Soo Chun1,2, Minjong Lee1,2 |
1Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea 2Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, Korea |
|
Received: February 2, 2025 Accepted: February 7, 2025 |
|
KeyWords:
Metabolic dysfunction-associated steatotic liver disease; chronic liver disease; hepatocellular carcinoma; risk stratification |
|
|